All lobbying filings

THE CONAFAY GROUP, LLC

THE CONAFAY GROUP, LLC filed a Q3 report for MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG) on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG) · fill in

All filings by THE CONAFAY GROUP, LLC · Everything MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG) has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 20, 2026.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

DARIN L GARDNER

Previously held: Legislative Correspondent Senator Tim Hutchinson; Research Assistant Senate HELP Committee; Chief of Staff Congresswoman Kay Granger
JOSH NARROW

Previously held: Intern Senator Casey

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

FY27 appropriations; education about the microbiome and federal research opportunities. FDA reforms.

Medical/Disease Research/Clinical Labs

FY27 appropriations; education about the microbiome and federal research opportunities. FDA reforms.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.